Inspections: Drug Manufacturing


NAC 585.630 Inspections.

  • The Commissioner will make an initial inspection of a licensee’s plant before the license is granted. At least annually the Commissioner will make such additional inspections as he or she deems necessary for enforcement of chapter 585 of NRS and NAC 585.010 to 585.640, inclusive
  • A licensee shall permit the Commissioner or his or her agent, after proper identification, to enter at any reasonable time any drug manufacturing, processing or packaging plant of the licensee within the State of Nevada to make an inspection to determine compliance with chapter 585 of NRS and NAC 585.010 to 585.640, inclusive. The licensee shall permit the Commissioner or the agent to examine the records of the establishment to obtain pertinent information.
  • After an inspection is made, the Commissioner will prepare a written report of the inspection and give a copy of the report to the licensee. Whenever the licensee is found not to be in compliance with NAC 585.010 to 585.640, inclusive, the Commissioner will take action pursuant to chapter 585 of NRS.
  • The Commissioner or his or her agent will pick up samples of finished drugs or their components from time to time and take the samples for testing at a laboratory approved by the Commissioner. Samples of finished drugs will be picked up and tested at least two times a year.
Last Updated: 7/15/2015